• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性腹外型纤维瘤病手术后局部复发。

Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis.

机构信息

Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands.

出版信息

Br J Surg. 2013 Aug;100(9):1214-9. doi: 10.1002/bjs.9194. Epub 2013 Jun 27.

DOI:10.1002/bjs.9194
PMID:23804156
Abstract

BACKGROUND

Desmoid-type fibromatosis is a locally aggressive soft tissue tumour with a biological behaviour that varies between relatively indolent and progressive growth. Although there is a trend towards conservative treatment, surgery remains the standard treatment for extra-abdominal desmoid tumours.

METHODS

Databases of three hospitals were searched to identify patients who had been treated for desmoid-type fibromatosis between November 1989 and May 2011. The risk of local recurrence was evaluated and predictive factors were assessed in patients who underwent surgical resection as initial treatment for a primary tumour.

RESULTS

A total of 132 patients had surgical treatment for a primary tumour. A complete resection (R0) was achieved in 87 patients (65.9 per cent). In addition to surgery, 54 patients received radiotherapy. During a median follow-up of 38 months, 18 local recurrences were detected. The estimated 5-year cumulative risk of local recurrence was 17.6 per cent. Univariable Cox regression analysis demonstrated that the risk of local recurrence increased for extremity lesions compared with desmoids on the trunk (odds ratio 6.69, 95 per cent confidence interval 1.42 to 31.54). No significant influence of age, resection margins or adjuvant radiotherapy on the risk for local recurrence was observed.

CONCLUSION

Following surgical treatment of a primary extra-abdominal desmoid tumour, the 5-year risk of local recurrence is modest and not influenced by microscopically clear resection margins or adjuvant radiotherapy.

摘要

背景

韧带样纤维瘤病是一种局部侵袭性软组织肿瘤,其生物学行为在相对惰性和进行性生长之间变化。尽管有向保守治疗的趋势,但手术仍然是治疗腹外型韧带样纤维瘤病的标准治疗方法。

方法

检索了三所医院的数据库,以确定 1989 年 11 月至 2011 年 5 月期间接受过韧带样纤维瘤病治疗的患者。评估了手术切除作为原发性肿瘤初始治疗的患者的局部复发风险,并评估了预测因素。

结果

共有 132 名患者接受了手术治疗。87 名患者(65.9%)达到了完全切除(R0)。除手术外,54 名患者还接受了放疗。在中位随访 38 个月期间,检测到 18 例局部复发。估计 5 年局部复发的累积风险为 17.6%。单变量 Cox 回归分析表明,与躯干上的韧带样纤维瘤相比,四肢病变的局部复发风险增加(优势比 6.69,95%置信区间 1.42 至 31.54)。未观察到年龄、切除边缘或辅助放疗对局部复发风险的显著影响。

结论

在对腹外型韧带样纤维瘤病的原发性肿瘤进行手术治疗后,5 年局部复发的风险适中,不受显微镜下无肿瘤残留的切除边缘或辅助放疗的影响。

相似文献

1
Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis.原发性腹外型纤维瘤病手术后局部复发。
Br J Surg. 2013 Aug;100(9):1214-9. doi: 10.1002/bjs.9194. Epub 2013 Jun 27.
2
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.CTNNB1 45F 突变是术后原发性硬纤维瘤复发的分子预后标志物:一项独立的多中心验证研究。
Cancer. 2013 Oct 15;119(20):3696-702. doi: 10.1002/cncr.28271. Epub 2013 Jul 31.
3
Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution.腹外及腹壁硬纤维瘤的预后因素:单机构20年经验
J Surg Oncol. 2009 Dec 1;100(7):563-9. doi: 10.1002/jso.21384.
4
Chest-wall desmoid tumors: results of surgical intervention.胸壁硬纤维瘤:手术干预结果
Ann Thorac Surg. 2004 Oct;78(4):1219-23; discussion 1219-23. doi: 10.1016/j.athoracsur.2004.03.015.
5
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series.腹壁外纤维瘤病:外科系列中的预后因素和结果分析。
Ann Surg Oncol. 2012 Dec;19(13):4028-35. doi: 10.1245/s10434-012-2638-2. Epub 2012 Sep 11.
6
Desmoid tumors: need for an individualized approach.硬纤维瘤:需要个体化治疗方法。
Expert Rev Anticancer Ther. 2009 Apr;9(4):525-35. doi: 10.1586/era.09.9.
7
[Extra-abdominal desmoid tumors: 7-year outcome after surgical treatment in 12 patients].[腹外硬纤维瘤:12例患者手术治疗后的7年随访结果]
Rev Chir Orthop Reparatrice Appar Mot. 2003 Sep;89(5):385-92.
8
[Therapeutic options for aggressive fibromatosis].[侵袭性纤维瘤病的治疗选择]
Handchir Mikrochir Plast Chir. 2008 Apr;40(2):88-93. doi: 10.1055/s-2007-965738.
9
Surgical outcome of desmoid tumors: adjuvant radiotherapy delayed the recurrence, but did not affect long-term outcomes.手术治疗硬纤维瘤的效果:辅助放疗虽可延迟复发,但并不影响长期预后。
J Surg Oncol. 2013 Jul;108(1):28-33. doi: 10.1002/jso.23343. Epub 2013 Apr 26.
10
[Evaluation of prognostic factors affecting recurrences and disease-free survival in extra-abdominal desmoid tumors].[影响腹外硬纤维瘤复发及无病生存的预后因素评估]
Acta Orthop Traumatol Turc. 2007 Aug-Oct;41(4):291-4.

引用本文的文献

1
Giant desmoid tumor of the abdominal wall: a case report.腹壁巨大硬纤维瘤:一例报告
Int J Surg Case Rep. 2025 May;130:111304. doi: 10.1016/j.ijscr.2025.111304. Epub 2025 Apr 15.
2
Risk factors and protective measures for desmoid tumours in familial adenomatous polyposis: retrospective cohort study.家族性腺瘤性息肉病中硬纤维瘤的危险因素及保护措施:回顾性队列研究
BJS Open. 2024 Dec 30;9(1). doi: 10.1093/bjsopen/zrae148.
3
Unraveling the Mystery of Desmoid Tumors: Insights From a Moroccan Tertiary Center.揭开韧带样瘤之谜:来自摩洛哥三级医疗中心的见解
Cureus. 2024 Apr 7;16(4):e57768. doi: 10.7759/cureus.57768. eCollection 2024 Apr.
4
Current Treatment Concepts for Extra-Abdominal Desmoid-Type Fibromatosis: A Narrative Review.腹外硬纤维瘤型纤维瘤病的当前治疗理念:一项叙述性综述
Cancers (Basel). 2024 Jan 8;16(2):273. doi: 10.3390/cancers16020273.
5
Desmoid Tumors: A Comprehensive Review.韧带样纤维瘤:全面综述。
Adv Ther. 2023 Sep;40(9):3697-3722. doi: 10.1007/s12325-023-02592-0. Epub 2023 Jul 12.
6
Evaluation of outcomes in the management of primary sporadic desmoid-type fibromatosis at a specialist soft tissue sarcoma unit.评估在一家软组织肉瘤专科治疗原发性散发性纤维瘤病的结果。
Eur J Med Res. 2022 Jul 16;27(1):123. doi: 10.1186/s40001-022-00751-7.
7
Surgical Management of a Giant Desmoid Fibromatosis of Abdominal Wall With Vessels Invasion in a Young Man: A Case Report and Review of the Literature.一名青年男性腹壁巨大侵袭血管性硬纤维瘤的外科治疗:病例报告及文献复习
Front Surg. 2022 Apr 11;9:851164. doi: 10.3389/fsurg.2022.851164. eCollection 2022.
8
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study.系统化疗在非典型性纤维黄色瘤中保留抗肿瘤活性,与 CTNNB1 或 APC 中的特定突变无关:一项多机构回顾性研究。
Clin Cancer Res. 2022 Sep 15;28(18):4092-4104. doi: 10.1158/1078-0432.CCR-21-4504.
9
Postoperative Adjuvant Radiotherapy Can Delay the Recurrence of Desmoid Tumors After R0 Resection in Certain Subgroups.术后辅助放疗可延缓特定亚组R0切除后硬纤维瘤的复发。
Front Surg. 2021 Sep 13;8:697793. doi: 10.3389/fsurg.2021.697793. eCollection 2021.
10
The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)-A Protocol for an International Cohort Study.韧带样型纤维瘤病患者健康相关生活质量问题的评估(QUALIFIED研究)——一项国际队列研究方案
Cancers (Basel). 2021 Jun 22;13(13):3068. doi: 10.3390/cancers13133068.